{
    "nctId": "NCT00984399",
    "briefTitle": "Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen",
    "officialTitle": "Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen",
    "overallStatus": "COMPLETED",
    "conditions": "Atrophic Vaginitis, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "To determine the change in estradiol and follicle stimulating hormone (FSH) from baseline to twelve weeks in postmenopausal women receiving adjuvant aromatase inhibitors during treatment with low dose vaginal 10 \u00b5g 17- \u03b2 estradiol.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* History of breast cancer, stages I-III with pathology confirmed at MSKCC\n* Women who have completed all of their primary treatment (surgery, radiation therapy, adjuvant chemotherapy) with the exception of endocrine therapy and currently have no clinical evidence of disease.\n* Women who are currently on aromatase inhibitors for at least three months--either letrozole or anastrozole\n* Women with symptomatic urogenital atrophy: vaginal dryness, irritation, pruritus, dyspareunia, urinary frequency and/or urinary incontinence\n* Menopausal at study entry defined as:\n\n  * Bilateral salpingo-oophorectomy independent of age\n  * If natural menopause, age \u2265 50 with cessation of menses for at least 12 months\n  * If menopause induced by chemotherapy, age \u2265 50 with no menstrual period at least 12 months after chemotherapy finished\n* At least 18 years of age\n* Able to participate in the informed consent process\n* Gynecology examination within six months\n* Able to read/speak English\n\nExclusion Criteria:\n\n* Inability to give informed consent\n* Vaginal bleeding of unknown etiology within 12 months of study entry\n* History of prior vaginal 17-\u03b2 estradiol or other topical estrogen use within the past six months",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}